Celsion (CLSN) Reports Publication of the Study of ThermoDox and Ultrasound in the Journal of Therapeutic Ultrasound
Tweet Send to a Friend
Celsion Corporation (NASDAQ: CLSN) today announced publication of the manuscript, "Clinical trial protocol for TARDOX: a phase I study to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
